Home
>
National Drug Code (NDC)
>
ELELYSO
ELELYSO - 0069-0106-01 - (Taliglucerase alfa)
Drug Information of ELELYSO
| Product NDC: | 0069-0106 |
| Proprietary Name: | ELELYSO |
| Non Proprietary Name: | Taliglucerase alfa |
| Active Ingredient(s): | 200 U/5mL & nbsp; Taliglucerase alfa |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ELELYSO
| Product NDC: | 0069-0106 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022458 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120501 |
Package Information of ELELYSO
| Package NDC: | 0069-0106-01 |
| Package Description: | 1 VIAL, GLASS in 1 BOX (0069-0106-01) > 5 mL in 1 VIAL, GLASS |
NDC Information of ELELYSO
| NDC Code | 0069-0106-01 |
| Proprietary Name | ELELYSO |
| Package Description | 1 VIAL, GLASS in 1 BOX (0069-0106-01) > 5 mL in 1 VIAL, GLASS |
| Product NDC | 0069-0106 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Taliglucerase alfa |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120501 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | TALIGLUCERASE ALFA |
| Strength Number | 200 |
| Strength Unit | U/5mL |
| Pharmaceutical Classes | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC],Glucosylceramidase [Chemical/Ingredient] |
